Purchases and Sales Made in Q4 2022 in Moon Lake Immunotherapeutics (MLTX)
This table provides information about the institutional ownership of Moon Lake Immunotherapeutics (MLTX) during Q4 2022. The information is specifically focused on institutions that hold shares of MoonLake Immunotherapeutics.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
Polar Capital Holdings PLC
London, X0 |
BUY
|
- |
876KNew |
$6.18M - $9.2M
|
876K
$43.2M
|
|
|
Feb 14, 2023
Q4 2022
|
Axa S.A.
Paris, I0 |
BUY
|
- |
405KNew |
$2.86M - $4.26M
|
405K
$20M
|
|
|
Feb 14, 2023
Q4 2022
|
Braidwell LP
Stamford, CT |
BUY
|
- |
381KNew |
$2.69M - $4M
|
381K
$18.8M
|
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
200K+ 7.45% |
$1.41M - $2.1M
|
2.89M
$142M
|
|
|
Feb 14, 2023
Q4 2022
|
Great Point Partners LLC
Greenwich, CT |
BUY
|
- |
151K+ 30.6% |
$1.06M - $1.58M
|
643K
$31.7M
|
|
|
Feb 14, 2023
Q4 2022
|
Balyasny Asset Management LLC
Chicago, IL |
BUY
|
- |
118K+ 118.27% |
$833K - $1.24M
|
218K
$10.7M
|
|
|
Feb 14, 2023
Q4 2022
|
Acuta Capital Partners, LLC
Belmont, CA |
BUY
|
- |
93.5KNew |
$659K - $982K
|
93.5K
$4.61M
|
|
|
Feb 14, 2023
Q4 2022
|
Jefferies Financial Group Inc.
New York, NY |
BUY
|
- |
67.7KNew |
$477K - $710K
|
67.7K
$3.33M
|
|
|
Feb 13, 2023
Q4 2022
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
44.8KNew |
$316K - $471K
|
44.8K
$2.21M
|
|
|
Feb 13, 2023
Q4 2022
|
Barclays PLC
London, X0 |
BUY
|
- |
40.8K+ 268.49% |
$287K - $428K
|
56K
$2.76M
|
|
|
Feb 10, 2023
Q4 2022
|
Cheyne Capital Management (Uk) LLP
|
BUY
|
- |
32.1KNew |
$227K - $337K
|
32.1K
$1.58M
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
24.3K+ 782.74% |
$171K - $255K
|
27.4K
$1.35M
|
|
|
Feb 15, 2023
Q4 2022
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
14.4KNew |
$101K - $151K
|
14.4K
$709K
|
|
|
Feb 14, 2023
Q4 2022
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
12.4KNew |
$87.3K - $130K
|
12.4K
$610K
|
|
|
Feb 13, 2023
Q4 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
11.6KNew |
$81.8K - $122K
|
11.6K
$572K
|
|
|
Feb 13, 2023
Q4 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
11.5KNew |
$80.7K - $120K
|
11.5K
$564K
|
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
7.9KNew |
$55.7K - $83K
|
7.9K
$389K
|
|
|
Feb 09, 2023
Q4 2022
|
Citigroup Inc
|
BUY
|
- |
7.23K+ 4.54% |
$51K - $75.9K
|
166K
$8.19M
|
|
|
Feb 14, 2023
Q4 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
76New |
$536 - $798
|
76
$3.74K
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-74- 0.01% |
$522 - $777
|
742K
$36.5M
|
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-100- 0.98% |
$705 - $1.05K
|
10.1K
$498K
|
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-100- 0.98% |
$705 - $1.05K
|
10.1K
$498K
|
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
SELL
|
- |
-2.28K- 3.01% |
$16K - $23.9K
|
73.4K
$3.62M
|
|
|
Feb 13, 2023
Q4 2022
|
Meridian Wealth Management, LLC
|
SELL
|
- |
-12K- 44.44% |
$84.6K - $126K
|
15K
$739K
|
|
|
Sep 21, 2023
Q4 2022
|
Jefferies Financial Group Inc.
New York, NY |
SELL
|
- |
-26.1K- 27.87% |
$184K - $274K
|
67.7K
$3.33M
|
|
|
Feb 14, 2023
Q4 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-46.8K- 5.38% |
$330K - $491K
|
823K
$40.5M
|
|
|
Feb 14, 2023
Q4 2022
|
Tang Capital Management LLC
San Diego, CA |
SELL
|
- |
-73.3K- 22.98% |
$517K - $770K
|
246K
$12.1M
|